Global Human Chorionic Gonadotropin (HCG) Market Insights and Forecast to 2028

Report ID: 1802491 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Chorionic Gonadotropin (HCG) Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Natural Source Extraction
        1.2.3 Recombinant DNA Technology
    1.3 Market by Application
        1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Female Infertility Treatment
        1.3.3 Oligospermic Treatment
        1.3.4 Cryptorchidism Treatment
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Chorionic Gonadotropin (HCG) Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Chorionic Gonadotropin (HCG) Sales by Region
        2.4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022)
        2.4.2 Global Sales Human Chorionic Gonadotropin (HCG) by Region (2023-2028)
    2.5 Global Human Chorionic Gonadotropin (HCG) Revenue by Region
        2.5.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022)
        2.5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
        3.1.1 Global Top Human Chorionic Gonadotropin (HCG) Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Chorionic Gonadotropin (HCG) in 2021
    3.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers
        3.2.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotropin (HCG) Revenue in 2021
    3.3 Global Human Chorionic Gonadotropin (HCG) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Chorionic Gonadotropin (HCG) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Type
        4.1.1 Global Human Chorionic Gonadotropin (HCG) Historical Sales by Type (2017-2022)
        4.1.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type
        4.2.1 Global Human Chorionic Gonadotropin (HCG) Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    4.3 Global Human Chorionic Gonadotropin (HCG) Price by Type
        4.3.1 Global Human Chorionic Gonadotropin (HCG) Price by Type (2017-2022)
        4.3.2 Global Human Chorionic Gonadotropin (HCG) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Chorionic Gonadotropin (HCG) Sales by Application
        5.1.1 Global Human Chorionic Gonadotropin (HCG) Historical Sales by Application (2017-2022)
        5.1.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Application
        5.2.1 Global Human Chorionic Gonadotropin (HCG) Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    5.3 Global Human Chorionic Gonadotropin (HCG) Price by Application
        5.3.1 Global Human Chorionic Gonadotropin (HCG) Price by Application (2017-2022)
        5.3.2 Global Human Chorionic Gonadotropin (HCG) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Chorionic Gonadotropin (HCG) Market Size by Type
        6.1.1 North America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
        6.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
    6.2 North America Human Chorionic Gonadotropin (HCG) Market Size by Application
        6.2.1 North America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
        6.2.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
    6.3 North America Human Chorionic Gonadotropin (HCG) Market Size by Country
        6.3.1 North America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
        6.3.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Chorionic Gonadotropin (HCG) Market Size by Type
        7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
        7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
    7.2 Europe Human Chorionic Gonadotropin (HCG) Market Size by Application
        7.2.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
        7.2.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
    7.3 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country
        7.3.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
        7.3.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Type
        8.1.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Application
        8.2.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region
        8.3.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Type
        9.1.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
        9.1.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
    9.2 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Application
        9.2.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
        9.2.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
    9.3 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country
        9.3.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
        9.3.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Type
        10.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Application
        10.2.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Country
        10.3.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 EMD Serono, Inc
        11.1.1 EMD Serono, Inc Corporation Information
        11.1.2 EMD Serono, Inc Overview
        11.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 EMD Serono, Inc Recent Developments
    11.2 Ferring B.V
        11.2.1 Ferring B.V Corporation Information
        11.2.2 Ferring B.V Overview
        11.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Ferring B.V Recent Developments
    11.3 Merck & Co., Inc
        11.3.1 Merck & Co., Inc Corporation Information
        11.3.2 Merck & Co., Inc Overview
        11.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck & Co., Inc Recent Developments
    11.4 Bristol Myers Squibb Company
        11.4.1 Bristol Myers Squibb Company Corporation Information
        11.4.2 Bristol Myers Squibb Company Overview
        11.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bristol Myers Squibb Company Recent Developments
    11.5 Fresenius Kabi AG, LLC
        11.5.1 Fresenius Kabi AG, LLC Corporation Information
        11.5.2 Fresenius Kabi AG, LLC Overview
        11.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Fresenius Kabi AG, LLC Recent Developments
    11.6 Scrippslabs
        11.6.1 Scrippslabs Corporation Information
        11.6.2 Scrippslabs Overview
        11.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Scrippslabs Recent Developments
    11.7 Leebio
        11.7.1 Leebio Corporation Information
        11.7.2 Leebio Overview
        11.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Leebio Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Leebio Recent Developments
    11.8 Kamiya Biomedical Company
        11.8.1 Kamiya Biomedical Company Corporation Information
        11.8.2 Kamiya Biomedical Company Overview
        11.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Kamiya Biomedical Company Recent Developments
    11.9 Sanzyme
        11.9.1 Sanzyme Corporation Information
        11.9.2 Sanzyme Overview
        11.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sanzyme Recent Developments
    11.10 Cigna
        11.10.1 Cigna Corporation Information
        11.10.2 Cigna Overview
        11.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Cigna Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Cigna Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
    12.2 Human Chorionic Gonadotropin (HCG) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Chorionic Gonadotropin (HCG) Production Mode & Process
    12.4 Human Chorionic Gonadotropin (HCG) Sales and Marketing
        12.4.1 Human Chorionic Gonadotropin (HCG) Sales Channels
        12.4.2 Human Chorionic Gonadotropin (HCG) Distributors
    12.5 Human Chorionic Gonadotropin (HCG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Chorionic Gonadotropin (HCG) Industry Trends
    13.2 Human Chorionic Gonadotropin (HCG) Market Drivers
    13.3 Human Chorionic Gonadotropin (HCG) Market Challenges
    13.4 Human Chorionic Gonadotropin (HCG) Market Restraints
14 Key Findings in The Global Human Chorionic Gonadotropin (HCG) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Natural Source Extraction
    Table 3. Major Manufacturers of Recombinant DNA Technology
    Table 4. Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022) & (K Units)
    Table 7. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)
    Table 8. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2023-2028) & (K Units)
    Table 9. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2023-2028)
    Table 10. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2017-2022)
    Table 12. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2023-2028)
    Table 14. Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers (2017-2022)
    Table 16. Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2017-2022)
    Table 18. Human Chorionic Gonadotropin (HCG) Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Human Chorionic Gonadotropin (HCG) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2021)
    Table 21. Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Chorionic Gonadotropin (HCG) Product Offered
    Table 23. Date of Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 26. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 27. Global Human Chorionic Gonadotropin (HCG) Sales Share by Type (2017-2022)
    Table 28. Global Human Chorionic Gonadotropin (HCG) Sales Share by Type (2023-2028)
    Table 29. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Type (2017-2022)
    Table 32. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Type (2023-2028)
    Table 33. Human Chorionic Gonadotropin (HCG) Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Human Chorionic Gonadotropin (HCG) Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 36. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 37. Global Human Chorionic Gonadotropin (HCG) Sales Share by Application (2017-2022)
    Table 38. Global Human Chorionic Gonadotropin (HCG) Sales Share by Application (2023-2028)
    Table 39. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Application (2017-2022)
    Table 42. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Application (2023-2028)
    Table 43. Human Chorionic Gonadotropin (HCG) Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Human Chorionic Gonadotropin (HCG) Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 46. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 47. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 50. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 51. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
    Table 54. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
    Table 55. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
    Table 105. EMD Serono, Inc Corporation Information
    Table 106. EMD Serono, Inc Description and Major Businesses
    Table 107. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. EMD Serono, Inc Recent Developments
    Table 110. Ferring B.V Corporation Information
    Table 111. Ferring B.V Description and Major Businesses
    Table 112. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Ferring B.V Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Ferring B.V Recent Developments
    Table 115. Merck & Co., Inc Corporation Information
    Table 116. Merck & Co., Inc Description and Major Businesses
    Table 117. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Merck & Co., Inc Recent Developments
    Table 120. Bristol Myers Squibb Company Corporation Information
    Table 121. Bristol Myers Squibb Company Description and Major Businesses
    Table 122. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Bristol Myers Squibb Company Recent Developments
    Table 125. Fresenius Kabi AG, LLC Corporation Information
    Table 126. Fresenius Kabi AG, LLC Description and Major Businesses
    Table 127. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Fresenius Kabi AG, LLC Recent Developments
    Table 130. Scrippslabs Corporation Information
    Table 131. Scrippslabs Description and Major Businesses
    Table 132. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Scrippslabs Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Scrippslabs Recent Developments
    Table 135. Leebio Corporation Information
    Table 136. Leebio Description and Major Businesses
    Table 137. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Leebio Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Leebio Recent Developments
    Table 140. Kamiya Biomedical Company Corporation Information
    Table 141. Kamiya Biomedical Company Description and Major Businesses
    Table 142. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Kamiya Biomedical Company Recent Developments
    Table 145. Sanzyme Corporation Information
    Table 146. Sanzyme Description and Major Businesses
    Table 147. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Sanzyme Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Sanzyme Recent Developments
    Table 150. Cigna Corporation Information
    Table 151. Cigna Description and Major Businesses
    Table 152. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Cigna Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Cigna Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Human Chorionic Gonadotropin (HCG) Distributors List
    Table 158. Human Chorionic Gonadotropin (HCG) Customers List
    Table 159. Human Chorionic Gonadotropin (HCG) Market Trends
    Table 160. Human Chorionic Gonadotropin (HCG) Market Drivers
    Table 161. Human Chorionic Gonadotropin (HCG) Market Challenges
    Table 162. Human Chorionic Gonadotropin (HCG) Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
    Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Share by Type in 2021 & 2028
    Figure 3. Natural Source Extraction Product Picture
    Figure 4. Recombinant DNA Technology Product Picture
    Figure 5. Global Human Chorionic Gonadotropin (HCG) Market Share by Application in 2021 & 2028
    Figure 6. Female Infertility Treatment
    Figure 7. Oligospermic Treatment
    Figure 8. Cryptorchidism Treatment
    Figure 9. Others
    Figure 10. Human Chorionic Gonadotropin (HCG) Report Years Considered
    Figure 11. Global Human Chorionic Gonadotropin (HCG) Sales 2017-2028 (K Units)
    Figure 12. Global Human Chorionic Gonadotropin (HCG) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Human Chorionic Gonadotropin (HCG) Revenue 2017-2028 (US$ Million)
    Figure 14. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)
    Figure 16. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2023-2028)
    Figure 17. North America Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Human Chorionic Gonadotropin (HCG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Human Chorionic Gonadotropin (HCG) in the World: Market Share by Human Chorionic Gonadotropin (HCG) Revenue in 2021
    Figure 29. Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 31. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 32. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 33. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 34. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 35. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 36. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 37. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 38. North America Human Chorionic Gonadotropin (HCG) Sales Share by Country (2017-2028)
    Figure 39. North America Human Chorionic Gonadotropin (HCG) Revenue Share by Country (2017-2028)
    Figure 40. U.S. Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 43. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 45. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Human Chorionic Gonadotropin (HCG) Sales Share by Country (2017-2028)
    Figure 47. Europe Human Chorionic Gonadotropin (HCG) Revenue Share by Country (2017-2028)
    Figure 48. Germany Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 49. France Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Share by Region (2017-2028)
    Figure 59. China Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 62. India Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Human Chorionic Gonadotropin (HCG) Sales Share by Country (2017-2028)
    Figure 74. Latin America Human Chorionic Gonadotropin (HCG) Revenue Share by Country (2017-2028)
    Figure 75. Mexico Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Share by Country (2017-2028)
    Figure 84. Turkey Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Human Chorionic Gonadotropin (HCG) Revenue (2017-2028) & (US$ Million)
    Figure 87. Human Chorionic Gonadotropin (HCG) Value Chain
    Figure 88. Human Chorionic Gonadotropin (HCG) Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Frequently Asked Questions
Human Chorionic Gonadotropin (HCG) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Chorionic Gonadotropin (HCG) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Chorionic Gonadotropin (HCG) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports